성별에 따른 원발성 폐선암 환자들의 차이
Sex-related Clinicopathologic Differences in Patients with Adenocarcinoma of the Lung
장희경 (고신대학교)
정만홍 (고신대학교)
장태원 (고신대학교)
장리라 (고신의대)
백종현 (고신의대)
옥철호 (고신대학교)
- 다운로드 수
- 조회수
초록
연구배경: 원발성 폐 선암은 다른 비소세포암에 비해 흡연과의 연관성이 상대적으로 적고 최근 증가 추세에 있으며 여성에서 많이 발생하는 특징을 가진 암종으로 폐 선암의 남녀 차이를 알아보고자 하였다.대상 및 방법: 1999년 1월부터 2005년 12월까지 고신대학교 병원에 내원하여 폐 선암으로 처음으로 진단된 환자 438명을 대상으로 혈액학적, 흡연력, 돌연변이, 병리조직, 생존 기간 및 치료방법에 따른 반응 등을 조사하여 폐 선암으로 진단받은 환자의 남녀간 차이를 비교분석하였다. 결 과: 총 438명의 환자 중 남성이 259명(59.1%), 여성이 179명(40.1%)으로 남성이 많았고, 50세 이전에서의 남녀 유병률은 여성이 25.8%로 남성의 17.7%에 비해 유의하게 높았다(p=0.02). 흡연율은 남성이 86%, 여성이 18%로 남성에서 월등히 높았고(p=0.000), 전체 중간 생존기간은 남성이 639일, 여성이 823일로 여성에서 높았다(p=0.01). 전혈구검사상 혈색소가 12 g/dL 미만인 경우는 여성이 64.6%로 남성의 32.4% 비해 유의하게 높았고(p=0.001), 종양 표지자 중 CEA가 5 ng/ml 이상인 경우는 여성이 68.1%로 남성의 32.1%에 비해 유의하게 높았다(p=0.000). 병기에 따른 남녀 구성비의 차이는 보이지 않았고, EGFR 및 K-ras 돌연변이도 남녀 간 차이는 보이지 않았으며, 조직학적 소견상 기관지 폐포암의 성분을 포함하고 있었던 경우는 여성에서 20명(11.2%), 남성에서 13명(5.0%)으로 여성에서 유의하게 높았다(p=0.035). 수술을 받은 76명의 환자를 다시 항암치료를 받은 군(57명)과 항암치료를 받지 않은 군(19명)으로 나누어 생존기간을 비교한 결과 남녀 모두 항암치료를 병행한 군에서 생존기간이 유의하게 연장되었음을 확인할 수 있었고(p<0.001), 수술만 받은 환자군에서는 남녀간 생존기간의 차이를 보이지 않았지만, 수술과 항암 치료를 병행한 군에서는 통계적 유의성은 가지지 못했으나 남성에 비해 여성에서 생존기간이 더 연장되는 경향을 보였다(p=0.054).
- keywords
- Adenocarcinoma, Gender, Survival., Adenocarcinoma, Gender, Survival.
Abstract
Background: The incidence of adenocarcinoma of the lung has been increasing worldwide, and it has been generally been accepted to be relatively unrelated to smoking with a female preponderance. The aim of this study was to examine the gender-related pathological and survival differences in patients with an adenocarcinoma of the lung. Material and Method: A retrospective review of the clinical information of patients diagnosed with an adenocarcinoma of the lung at Kosin Medical Center from January 1999 to September 2005 was performed. The patient's demographics (age, gender), smoking history, stage, serum tumor marker, pathology classification, EGFR mutation, K-ras mutation, treatment methods, and survival time were analyzed. Result: Of the 438 patients, 179 (40.9%) were female. The median age at the diagnosis was 58 years for females and 59 years for males. However, 25.8% of women and only 17.7% of men were under 50 years of age (p=0.02). The distribution of the disease stage was similar in both men and women. The bronchioloalveolar carcinoma component was diagnosed more often in women (11.2%) than in men (5.0%). The overall survival rate was higher in women than in men (p=0.01), and women had a superior therapeutic response to a combined treatment of surgery and chemotherapy. Conclusion: This study showed significant genders differences in terms of the smoking history, bronchioloalveolar carcinoma component, overall survival, and survival after combined treatment of surgery and chemotherapy. Therefore, gender differences should be considered when diagnosing and treating adenocarcinomas of the lung. (Tuberc Respir Dis 2007; 62: 203-210)
- keywords
- Adenocarcinoma, Gender, Survival., Adenocarcinoma, Gender, Survival.
참고문헌
(jama1989;261) Trends in cigarette smoking in United States the changing influence of gender and race,
(2004) Women's susceptibility to tobacco carcinogens,
(1825-30) Female-male differences in patients with primary lung cancer,
(epidemiology1992;3) Gender and histologic type variations in smoking-related risk of lung cancer,
(1996) United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females,
(2002) Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival,
Sex differences in lung-cancer risk associated with cigarette smoking,
Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features,
(1998) Analysis of cell type and radiographic presentation as predictors of the clinical course of patients with bronchioloalveolar cell carcinoma,
(1997) Cigarette smoking and changes in the histopathology of lung cancer,
(1995) Lung cancer pathology in smokers, ex-smokers and never smokers,
(2003) Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer ,
(2000) Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma,
(2006) An epidemiologic study of early onset lung cancer,
Fu JB, (2005) Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database,
O'Connell JP, (jclinoncol1986;4) Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy,
Minami H, (2000) Lung cancer in women sex-associated differences in survival of patients undergoing resection for lung cancer,
Alexiou C, (2002) Do women live longer following lung resection for carcinoma? ,
Ferguson MK, (2000) Sex-associated differences in survival of patients undergoing resection for lung cancer,
Risch HA, (amjepidemiol1993;138) Are female smokers at higher risk for lung cancer than male smokers? A case control analysis by histologic type,
Kure EH, (1996) p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels,
Ryberg D, Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients,
Mollerup S, (1999) Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients,
Nelson HH, (1999) Implications and prognostic value of K-ras mutation for early-stage lung cancer in women,
Caracta CF, (1999) Estrogen receptor status of lung cancer cell lines ,
(1996) Preferential formation of benzo [] pyrene adducts at lung cancer mutational hotspots in p53,
(eurrespirj1994;71877-88) Exposure to environmental tobacco smoke and risk of lung cancer,
(1996) Familial risk of lung cancer among nonsmokers and their relatives,
Increased familial risk for lung cancer,
(2000) Chinese food cooking and lung cancer in women nonsmokers,
Epidemiology and etiology of lung cancer, Clin Chest Med 1993;14
(2001) The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women,
(1999) Previous lung disease and risk of lung cancer among men and women nonsmokers,
(2002) Gender- dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue,
(2001) Expression, function, and clinical implications of estrogen receptor ß in human lung cancers,
Endocrine factors and adenocarcinoma of the lung in women,
(1996) Bronchioloalveolar carcinoma,
(2002) A time trend of profile and surgical results in 1123 patients with non-small cell lung cancer,
(2000) Evaluation of HER-2/neu expression on lung tumors by immunohistochemistry and fluorescence in situ hybridization ,
(1995) Expression and activation of erb-2 and epidermal growth factor receptor in lung adenocarcinomas,
(2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk,
(2003) Genetic susceptibility to lung cancer the role of DNA damage and repair,
(2002) Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer,
(2000) Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small cell lung cancer (LA-NSCLC): identification of five groups with different survival,
(jclinoncol1991;9) Survival determinants in extensive-stage non-small cell lung cancer,
- 다운로드 수
- 조회수
- 0KCI 피인용수
- 0WOS 피인용수